Literature DB >> 12632482

Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.

Lun-Xiu Qin1, Zhao-You Tang.   

Abstract

Obstructive jaundice as the main clinical feature is uncommon in patients with hepatocellular carcinoma (HCC). Only 1-12 % of HCC patients manifest obstructive jaundice as the initial complaint. Such cases are clinically classified as "icteric type hepatoma", or "cholestatic type of HCC". Identification of this group of patients is important, because surgical treatment may be beneficial. HCC may involve the biliary tract in several different ways: tumor thrombosis, hemobilia, tumor compression, and diffuse tumor infiltration. Bile duct thrombosis (BDT) is one of the main causes for obstructive jaundice, and the previously reported incidence is 1.2-9 %. BDT might be benign, malignant, or a combination of both. Benign thrombi could be blood clots, pus, or sludge. Malignant thrombi could be primary intrabiliary malignant tumors, HCC with invasion to bile ducts, or metastatic cancer with bile duct invasion. The common clinical features of this type of HCC include: high level of serum AFP; history of cholangitis with dilation of intrahepatic bile duct; aggravating jaundice and rapidly developing into liver dysfunction. It is usually difficult to make diagnosis before operation, because of the low incidence rate, ignorant of this disease, and the difficulty for the imaging diagnosis to find the BDT preoperatively. Despite recent remarkable improvements in the imaging tools for diagnosis of HCC, such cases are still incorrectly diagnosed as cholangiocarcinoma or choledocholithiases. Ultrasonography (US) and CT are helpful in showing hepatic tumors and dilated intrahepatic and /or extrahepatic ducts containing dense material corresponding to tumor debris. Direct cholangiography including percutaneous transhepatic cholangiography (PTC) and endoscopic retrograde cholangiopancreatography (ERCP) remains the standard procedure to delineate the presence and level of biliary obstruction. Magnetic resonance cholangiopancreatography (MRCP) is superior to ERCP in interpreting the cause and depicting the anatomical extent of the perihilar obstructive jaundice, and is particularly distinctive in cases associated with tight biliary stenosis and along segmental biliary stricture. Choledochoscopy and bile duct brushing cytology could be alternative useful techniques in the differentiating obstructions due to intraluminal mass, infiltrating ductal lesions or extrinsic mass compression applicable before and after duct exploration. Jaundice is not necessarily a contraindication for surgery. Most patients will have satisfactory palliation and occasional cure if appropriate procedures are selected and carried out safely, which can result in long-term resolution of symptoms and occasional long-term survival. However, the prognosis of icteric type HCC is generally dismal, but is better than those HCC patients who have jaundice caused by hepatic insufficiency.

Entities:  

Mesh:

Year:  2003        PMID: 12632482      PMCID: PMC4621546          DOI: 10.3748/wjg.v9.i3.385

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  70 in total

1.  Acute pancreatitis caused by hemobilia secondary to hepatoma with bile duct invasion.

Authors:  Li-Jung Tseng; Yeun Tarl Fresner N Jao; Lein-Ray Mo
Journal:  Gastrointest Endosc       Date:  2002-02       Impact factor: 9.427

2.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

3.  Icteric type hepatoma.

Authors:  T Y Lin; K M Chen; Y R Chen; W S Lin; T H Wang; J L Sung
Journal:  Med Chir Dig       Date:  1975

4.  Common bile duct obstruction by hepatoma.

Authors:  Y Kuroyanagi; M Sawada; R Hidemura; S Aoki; H Kato
Journal:  Am J Surg       Date:  1977-02       Impact factor: 2.565

5.  Bile duct obstruction in hepatocellular carcinoma (hepatoma)--clinical and cholangiographic characteristics. Report of 6 cases and review of the literature.

Authors:  E vanSonnenberg; J T Ferrucci
Journal:  Radiology       Date:  1979-01       Impact factor: 11.105

6.  Effective relief of obstructive jaundice in a patient with nonresectable icteric-type hepatocellular carcinoma by external beam radiation therapy: case report.

Authors:  K F Sung; N M Tsang; J H Tseng; C T Yeh
Journal:  Chang Gung Med J       Date:  2001-02

7.  Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion.

Authors:  A A Polydorou; S R Cairns; J F Dowsett; A R Hatfield; P R Salmon; P B Cotton; R C Russell
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

8.  Icteric type hepatocellular carcinoma: revisited 20 years later.

Authors:  G T Huang; J C Sheu; H S Lee; M Y Lai; T H Wang; D S Chen
Journal:  J Gastroenterol       Date:  1998-02       Impact factor: 7.527

9.  Combined hepatocellular carcinoma and cholangiocarcinoma growing into the common bile duct.

Authors:  M Saito; S Hige; H Takeda; U Tomaru; M Shibata; M Asaka
Journal:  J Gastroenterol       Date:  2001-12       Impact factor: 7.527

10.  Obstructive jaundice secondary to hepatocellular carcinoma.

Authors:  W Y Lau; K L Leung; T W Leung; S Ho; M Chan; C K Liew; N Leung; P Johnson; A K Li
Journal:  Surg Oncol       Date:  1995       Impact factor: 3.279

View more
  53 in total

1.  Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging.

Authors:  Tian Yang; Chuan Lin; Jian Zhai; Song Shi; Min Zhu; Nan Zhu; Jun-Hua Lu; Guang-Shun Yang; Meng-Chao Wu
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-10       Impact factor: 4.553

2.  Imaging diagnosis of pancreato-biliary diseases: a control study.

Authors:  Liang Zhong; Qiu-Ying Yao; Lei Li; Jian-Rong Xu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

3.  Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.

Authors:  Xing-Lei Qin; Zhuo-Ren Wang; Jing-Sen Shi; Min Lu; Lin Wang; Quan-Ru He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

4.  Ultrasound-guided endoscopic biliary drainage: a useful drainage method for biliary decompression in patients with biliary obstructions.

Authors:  Xiang Wu Jiang; Shao Hui Tang; Jian Quan Yang; Wei Huang
Journal:  Dig Dis Sci       Date:  2013-09-12       Impact factor: 3.199

5.  Relationship between body surface area and ALT normalization after long-term lamivudine treatment.

Authors:  Makoto Nakamuta; Shusuke Morizono; Yuichi Tanabe; Eiji Kajiwara; Junya Shimono; Akihide Masumoto; Toshihiro Maruyama; Norihiro Furusyo; Hideyuki Nomura; Hironori Sakai; Kazuhiro Takahashi; Koichi Azuma; Shinji Shimoda; Kazuhiro Kotoh; Munechika Enjoji; Jun Hayashi
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

Review 6.  Efficacy of 125I Versus Non-125I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice.

Authors:  Shuangxi Li; Xuewen He; Lei Dang; Fangyu Xu; Jin Fang; Fenqiang Li; Wenhui Wang
Journal:  Dig Dis Sci       Date:  2018-01-05       Impact factor: 3.199

7.  Bile duct thrombi in hepatocellular carcinoma: is aggressive surgery worthwhile?

Authors:  Ashwin Rammohan; Jeswanth Sathyanesan; Kamalakannan Rajendran; Anbalagan Pitchaimuthu; Senthil K Perumal; Kesavan Balaraman; Ravi Ramasamy; Ravichandran Palaniappan; Manoharan Govindan
Journal:  HPB (Oxford)       Date:  2015-01-09       Impact factor: 3.647

8.  Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi.

Authors:  Xian-huan Yu; Lei-bo Xu; Chao Liu; Rui Zhang; Jie Wang
Journal:  Dig Dis Sci       Date:  2010-05-01       Impact factor: 3.199

9.  Hepatocellular apoptosis after hepatectomy in obstructive jaundice in rats.

Authors:  De-Sheng Wang; Ke-Feng Dou; Kai-Zong Li; Zhi-Qing Gao; Zhen-Shun Song; Zheng-Cai Liu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

10.  Role of serum total sialic acid in differentiating cholangiocarcinoma from hepatocellular carcinoma.

Authors:  Prachya Kongtawelert; Pisit Tangkijvanich; Siriwan Ong-Chai; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.